These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23402846)

  • 1. Interactive design of generic chemical patterns.
    Schomburg KT; Wetzer L; Rarey M
    Drug Discov Today; 2013 Jul; 18(13-14):651-8. PubMed ID: 23402846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery FAQs: workflows for answering multidomain drug discovery questions.
    Chichester C; Digles D; Siebes R; Loizou A; Groth P; Harland L
    Drug Discov Today; 2015 Apr; 20(4):399-405. PubMed ID: 25463038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data structures and computational tools for the extraction of SAR information from large compound sets.
    Wawer M; Lounkine E; Wassermann AM; Bajorath J
    Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to molecular topology: basic concepts and application to drug design.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):196-223. PubMed ID: 22734705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the art of compiling and using 'drug-like' chemical fragment spaces.
    Degen J; Wegscheid-Gerlach C; Zaliani A; Rarey M
    ChemMedChem; 2008 Oct; 3(10):1503-7. PubMed ID: 18792903
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Guru: a computer software program for drug design using medicinal chemistry rules.
    Stewart KD; Shiroda M; James CA
    Bioorg Med Chem; 2006 Oct; 14(20):7011-22. PubMed ID: 16870456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative Chemical Patterns: Automatic and Interactive Design.
    Bietz S; Schomburg KT; Hilbig M; Rarey M
    J Chem Inf Model; 2015 Aug; 55(8):1535-46. PubMed ID: 26268674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.
    Camacho R; Pereira M; Costa VS; Fonseca NA; Adriano C; Simões CJ; Brito RM
    J Integr Bioinform; 2011 Sep; 8(3):182. PubMed ID: 21926445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraction and analysis of chemical modification patterns in drug development.
    Shigemizu D; Araki M; Okuda S; Goto S; Kanehisa M
    J Chem Inf Model; 2009 Apr; 49(4):1122-9. PubMed ID: 19391632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
    Griffen EJ; Dossetter AG; Leach AG; Montague S
    Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opportunities of mining historical and collective data in drug discovery.
    Wassermann AM; Lounkine E; Davies JW; Glick M; Camargo LM
    Drug Discov Today; 2015 Apr; 20(4):422-34. PubMed ID: 25463034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical structure montages as catalysts for design and discovery.
    Njarðarson JT
    Future Med Chem; 2012 May; 4(8):951-4. PubMed ID: 22650237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.